Lux Research Release: China Emerging as an Innovation Hub for Formulation and Delivery

Published: Feb 07, 2012

BOSTON--(BUSINESS WIRE)--A clutch of promising Chinese companies in the formulation and delivery (F/D) market underlines the emergence of the Asian giant as a center for biopharma innovation and entrepreneurship, even as Western pharmaceutical companies continue to enjoy technological and business advantages, according to a Lux Research report titled, “The Expanding Formulation and Delivery Market in China.”

Back to news